Dr Sanjeewa Kularatna
|Institute:||Queensland University of Technology|
Development of new methods to accurately measure heart disease outcomes
Australian government spends $7.7 billion annually to treat cardiovascular disease (CVD).
To identify the most cost-effective strategies from a myriad of interventions and to allocate resources efficiently, precise effectiveness measurement is of utmost importance.
Quality Adjusted Life Years (QALYs) is commonly used as a measure of health outcome in economic evaluation and health utility…